ClinicalTrials.gg
CompletedNCT03171181Updated May 11, 2018

Unilateral Peripheral Vestibular Dysfunction: Reeducation and Spatial Orientation.

An interventional study of Vestibular reeducation in Inner Ear Disease, Equilibrium; Disorder, Labyrinth and Spatial Navigation, sponsored by Universidad de Zaragoza. Completed at 1 site in Spain. Open to participants aged 18 Years to 66 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-05-11.

Sponsored by Universidad de Zaragoza · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 3 years 6 months after the study started (first participant enrolled Nov 2013, registered May 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Non-randomized
Ages
18 Years to 66 Years
Sex
All
01

Study summary

Motor control includes postural control and voluntary movement. For an optimal motor control it is necessary that brain integrates vestibular, visual and somatosensorial inputs properly, in a nonlinear way. Vestibular system, as an afferent organ, encodes head position in relation to gravity and changes in its linear and angular acceleration. As vestibular central system, it plays an essential role in motor control and in orientation and spatial memory as well.

When a peripheral vestibular lesion occurs, elaboration, interpretation and processing of inputs are deficient and therefore motor control is altered to a greater or lesser degree. As process progress in time, there is a natural neuroplasticity that facilitates recovery or compensate vestibular function, although sometimes this process is incomplete and requires vestibular reeducation This study aims to assess changes in balance control, orientation and handicap perception in one case group with symptomatic unilateral peripheral vestibular dysfunction, before and after a rehabilitation programme (RV). To compare values obtained at the beginning and at the end of RV to those achieved by control group. Finally, this research aims to analyse evolution of spatial orientation quality in symptomatic and non symptomatic participants.

Read the detailed description

Intervention group: 30 people with a unilateral peripheral vestibular disorder (UPVD). Process lasting more than three months and symptomatic. Aged 18-66 years old.

Control group: 30 participants without UPVD, healthy for the purpose of study. No intervention group: 30 people with a unilateral peripheral vestibular disorder without symptomatology. Both groups also aged 18-66.

Balance quality was registered with static and dynamic posturography. For spatial orientation is was registered Visual vertical and visual orientation perception. Vestibular disability was also assessed. Variables were registered at the beginning and at the end of a vestibular reeducation in UPVD participants. Vestibular reeducation consisted of 10 sessions of vestibular rehabilitation using dynamic posturography and visual reeducation. Duration of each session: 40 minutes. Twice a week.

The aim is to compare data before and after intervention with those obtained in compensated patients and control group.

02

Conditions studied

  • Inner Ear Disease
  • Equilibrium; Disorder, Labyrinth
  • Spatial Navigation

Keywords

  • Spatial cognition, vestibular system, motor control
03

In context

Labyrinth Diseases

21 studies on the registry are indexed under Labyrinth Diseases; 8 are open to participants now.

This study's enrollment of 90 is above the median of 37 across 16 interventional studies indexed under Labyrinth Diseases.

Browse Labyrinth Diseases studies →

Lead sponsor

Universidad de Zaragoza is the lead sponsor of 111 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 66 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • People diagnosed of UPVD
  • Length of process superior to three months
  • Normal vision or corrected by lens or glasses.

Exclusion criteria

Exclusion Criteria:

  • Dizziness or balance alteration due to visual problem or lesion of CNS (central nervous system).
  • Balance disturbance due to a locomotor cause
  • Balance perturbation next to resolve.
  • Sharpening or acute phase os symptoms.
  • Difficulties with understanding commands.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Single group
Masking
Single (Outcomes assessor)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    UPVD non compensated

    Intervention group: 30 participants with unilateral peripheral vestibular disorders. Exposed to vestibular reeducation.

    Other: Vestibular reeducation

  • No intervention
    control group

    Control group, to obtain reference values.

  • No intervention
    UPVD compensated

    Registered spatial orientation in a group of 30 participants with compensated lesion.

Interventions

  • OtherVestibular reeducation

    Balance quality was registered with static and dynamic posturography. For spatial orientation is was registered Visual vertical and visual orientation perception. Vestibular disability was also assessed. Variables were registered at the beginning and at the end of a vestibular rehabilitation in UPVD participants. Vestibular rehabilitation consisted of 10 sessions of vestibular rehabilitation using dynamic posturography and visual reeducation. Duration of each session: 40 minutes. Twice a week.

06

What researchers measure

Primary outcomes

  1. Changes in Visual vertical and visual orientation degrees at baseline and before treatment.

    Visual vertical and visual orientation were measured with bucket test

    Time frame: Outcomes were measured in patients at baseline and 3 months. Control group and compensated group were registered at baseline.

Secondary outcomes

  1. Balance quality.

    Balance quality was obtained from static and dynamic posturography

    Time frame: Outcomes were measured in patients at baseline and 3 months. Control group was registered at baseline.

Other outcomes

  1. Dizziness handicap inventory test.

    Quality of life was registered with Dizziness handicap inventory test (DHI).

    Time frame: Outcomes were measured in patients at baseline and 3 months.

07

Study locations

1 site
  • Facultad de Ciencias de la Salud
    Zaragoza, Aragon 50009, Spain
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data are: age, sex, side of lesion and pathology. Patients are coded, so name is only known by person who makes clinical registration.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: 2014-2018

Access criteria: affiliation code. The rest of information is shared.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2013 to primary completion in Mar 2015, 16 months.

How these figures are worked out, and which studies are left out of them.

Registered
May 24, 2017
First posted
May 31, 2017
StartActual
Nov 2013
Primary completionActual
Mar 2015
CompletionActual
Aug 30, 2015
Last update
May 11, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 11, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03171181
Collaborators
Aragon Institute of Health Sciences
Responsible party
Pilar Dominguez-Olivan (Ph D. Physical Therapist., Universidad de Zaragoza) — Principal investigator
First posted
May 31, 2017
Start date
Nov 2013
Primary completion
Mar 2015
Completion
Aug 30, 2015
Last update
May 11, 2018

Study contacts

Ana Bengoetxea-Arrese, PhD
principal investigator · Université Libre de Bruxelles

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion